156 related articles for article (PubMed ID: 33354827)
1. Factors associated with potential over- and undertreatment of hyperglycaemia and annual measurement of HbA
Tran AT; Berg TJ; Mdala I; Gjelsvik B; Cooper JG; Sandberg S; Claudi T; Jenum AK
Diabet Med; 2021 Aug; 38(8):e14500. PubMed ID: 33354827
[TBL] [Abstract][Full Text] [Related]
2. Distinct trajectories of HbA
Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
[TBL] [Abstract][Full Text] [Related]
3. Older people with Type 2 diabetes, including those with chronic kidney disease or dementia, are commonly overtreated with sulfonylurea or insulin therapies.
Hambling CE; Seidu SI; Davies MJ; Khunti K
Diabet Med; 2017 Sep; 34(9):1219-1227. PubMed ID: 28498634
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study of diabetes treatment in older adults: what should we AIM for?
Cigiloglu A; Efendioglu EM; Ozturk ZA
Postgrad Med; 2022 Sep; 134(7):693-697. PubMed ID: 35697060
[TBL] [Abstract][Full Text] [Related]
5. Are general practitioners characteristics associated with the quality of type 2 diabetes care in general practice? Results from the Norwegian ROSA4 study from 2014.
Tran AT; Bakke Å; Berg TJ; Gjelsvik B; Mdala I; Nøkleby K; Shakil Rai A; Cooper JG; Claudi T; Løvaas K; Thue G; Sandberg S; Jenum AK
Scand J Prim Health Care; 2018 Jun; 36(2):170-179. PubMed ID: 29717939
[TBL] [Abstract][Full Text] [Related]
6. Patterns of diabetes care in Slovenia, Croatia, Serbia, Bulgaria and Romania : An observational, non-interventional, cross-sectional study.
Cokolic M; Lalic NM; Micic D; Mirosevic G; Klobucar Majanovic S; Lefterov IN; Graur M
Wien Klin Wochenschr; 2017 Mar; 129(5-6):192-200. PubMed ID: 27933508
[TBL] [Abstract][Full Text] [Related]
7. Potential Overtreatment and Undertreatment of Type 2 Diabetes Mellitus in Long-Term Care Facilities: A Systematic Review.
Stasinopoulos J; Wood SJ; Bell JS; Manski-Nankervis JA; Hogan M; Sluggett JK
J Am Med Dir Assoc; 2021 Sep; 22(9):1889-1897.e5. PubMed ID: 34004183
[TBL] [Abstract][Full Text] [Related]
8. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
[TBL] [Abstract][Full Text] [Related]
9. Hypoglycaemia in the over 75s: Understanding the predisposing factors in type 2 diabetes (T2DM).
Heald AH; Anderson SG; Cortes GJ; Cholokova V; Narajos M; Khan A; Donnahey G; Livingston M
Prim Care Diabetes; 2018 Apr; 12(2):133-138. PubMed ID: 28941578
[TBL] [Abstract][Full Text] [Related]
10. Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.
Mata-Cases M; Benito-Badorrey B; Roura-Olmeda P; Franch-Nadal J; Pepió-Vilaubí JM; Saez M; Coll-de-Tuero G;
Curr Med Res Opin; 2013 Nov; 29(11):1495-502. PubMed ID: 23944631
[TBL] [Abstract][Full Text] [Related]
11. Recognition of fasting or overall hyperglycaemia when starting insulin treatment in patients with type 2 diabetes in general practice.
Vähätalo M; Rönnemaa T; Viikari J
Scand J Prim Health Care; 2007 Sep; 25(3):147-53. PubMed ID: 17846932
[TBL] [Abstract][Full Text] [Related]
12. Clinical inertia in basal insulin-treated patients with type 2 diabetes - Results from a retrospective database study in Japan (JDDM 43).
Satoh J; Andersen M; Bekker Hansen B; Larsen Thorsted B; Tutkunkardas D; Zacho M; Maegawa H
PLoS One; 2018; 13(9):e0198160. PubMed ID: 30226870
[TBL] [Abstract][Full Text] [Related]
13. Determinants of diagnostic discordance for non-diabetic hyperglycaemia and Type 2 diabetes using paired glycated haemoglobin measurements in a large English primary care population: cross-sectional study.
Bachmann MO; Lewis G; John WG; Turner J; Dhatariya K; Clark A; Pascale M; Sampson M;
Diabet Med; 2019 Nov; 36(11):1478-1486. PubMed ID: 31420897
[TBL] [Abstract][Full Text] [Related]
14. Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA
Young TK; Li JW; Kang A; Heerspink HJL; Hockham C; Arnott C; Neuen BL; Zoungas S; Mahaffey KW; Perkovic V; de Zeeuw D; Fulcher G; Neal B; Jardine M
Diabetologia; 2021 Nov; 64(11):2402-2414. PubMed ID: 34448033
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes.
Kim K; Unni S; Brixner DI; Thomas SM; Olsen CJ; Sterling KL; Mitchell M; McAdam-Marx C
Diabetes Obes Metab; 2019 Jul; 21(7):1725-1733. PubMed ID: 30848039
[TBL] [Abstract][Full Text] [Related]
16. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
[TBL] [Abstract][Full Text] [Related]
17. A Cross-Sectional Study of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Diabetes Mellitus: The TEMD Overtreatment Study.
Sonmez A; Tasci I; Demirci I; Haymana C; Barcin C; Aydin H; Cetinkalp S; Ozturk FY; Gul K; Sabuncu T; Satman I; Bayram F;
Diabetes Ther; 2020 May; 11(5):1045-1059. PubMed ID: 32088879
[TBL] [Abstract][Full Text] [Related]
18. Sodium-glucose co-transporter-2 inhibitors, the latest residents on the block: Impact on glycaemic control at a general practice level in England.
Heald AH; Fryer AA; Anderson SG; Livingston M; Lunt M; Davies M; Moreno GYC; Gadsby R; Young RJ; Stedman M
Diabetes Obes Metab; 2018 Jul; 20(7):1659-1669. PubMed ID: 29516618
[TBL] [Abstract][Full Text] [Related]
19. HYPERGLYCEMIA AND HYPOGLYCEMIA IN PATIENTS WITH DIABETES IN SKILLED NURSING FACILITIES.
Patell R; Nigmatoulline D; Bena J; Kim DG; Messinger-Rapport B; Lansang MC
Endocr Pract; 2017 Apr; 23(4):458-465. PubMed ID: 28156156
[TBL] [Abstract][Full Text] [Related]
20. Potential overtreatment and undertreatment of diabetes in different patient age groups in primary care after the introduction of performance measures.
de Vries ST; Voorham J; Haaijer-Ruskamp FM; Denig P
Diabetes Care; 2014; 37(5):1312-20. PubMed ID: 24595634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
